HOME >> MEDICINE >> NEWS
Better survival seen for early breast cancer patients switched from tamoxifen to Aromasin

ATLANTA, June 3, 2006 New data from the Intergroup Exemestane Study (IES) showed for the first time today that hormone sensitive postmenopausal early breast cancer patients who switched to Aromasin after 2 to 3 years of tamoxifen were 17% more likely to be alive and were 25% less likely to have their cancer return than patients who continued on tamoxifen for a full 5 years of therapy.

"Exemestane is the only anti-hormonal therapy that has been shown to demonstrate improved overall survival over tamoxifen alone," said Lead Investigator Professor Charles Coombes, director of cancer medicine, Imperial College, London. These significant survival benefits were seen in patients who are considered hormone sensitive, which represents 97% of the study population. Although not statistically significant in the intent to treat population, 15% of patients taking Aromasin were more likely to be alive versus those that continued on tamoxifen. These new findings were based on nearly 5 years of follow-up after randomization in the IES trial. IES was a large randomized double blind multinational trial of postmenopausal women with early breast cancer which was designed to compare the clinical benefits of switching 2352 patients to Aromasin after 2 to 3 years of tamoxifen versus continuing 2372 patients on tamoxifen for a full 5 years of therapy. The 5 year follow-up time includes a period of observation lasting over 2 years after completion of all treatment.

Earlier results of the IES trial, which led to US FDA and European regulatory approvals of Aromasin for treatment of early breast cancer, found that postmenopausal hormone receptor positive patients, which represented 85% of all patients in the trial, who switched to Aromasin reduced their risk of breast cancer recurring by 35% versus patients who stayed on tamoxifen for 5 years. At the earlier time point, a difference in overall survival had not been seen.

Breast cancer is one of the most comm
'"/>


3-Jun-2006


Page: 1 2 3

Related medicine news :

1. Better mobility keeps seniors healthier
2. Better insight into brain anatomical structures
3. Better health twice as likely for nonsmokers who live and work with smoking restrictions
4. Better designed roadway intersections can boost older drivers performance
5. Better strategies for osteoporosis prevention and therapy
6. Better review of new technology is needed to reduce health costs
7. Better training needed to reduce emergency caesareans
8. Better after-school snack choices boost nutrition for low-income kids, UC Davis research confirms
9. Outcomes of patients in trials; Better blood pressure treatment; Snake bites, and more
10. Better regulation needed for ethical research in Africa
11. Better procedures needed on care of prisoners in hospitals

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2016)... ... February 14, 2016 , ... With ProCel Parallax users now have the ability ... With ProCel Parallax each user has total control over angle of view, layer position, ... infinite possibilities. ProCel Parallax offers in and out animation, custom camera animations, text animations, ...
(Date:2/14/2016)... ... February 14, 2016 , ... Many eating disorder patients complete ... residence. The nature of the illnesses requires ongoing supervision, therapy and support. There ... work to make traditional appointments. These people struggle to maintain recovery or to ...
(Date:2/14/2016)... ... February 14, 2016 , ... ... Association of Heart Failure Nurses (AAHFN) is promoting healthier living with heart failure ... Spices of Life! Healthy Living with Heart Failure will kick-off February 14 and ...
(Date:2/13/2016)... ... February 13, 2016 , ... Good news for ... in the area to offer AngioPlex™ Optical Coherence Tomography (OCT) Angiography, imaging technology ... macular degeneration, diabetic retinopathy, and other vascular conditions. , In just a few ...
(Date:2/13/2016)... ... ... in Sun City is the place to be on March 3rd to learn about the ... be hosting this educational seminar from 5:30 p.m. – 7:00 p.m. Exciting advancements will be ... In addition, prizes will be given away and light refreshments will be served. , ...
Breaking Medicine News(10 mins):
(Date:2/14/2016)... 14, 2016  Ennaid Therapeutics, located in ... help the millions of people worldwide when infected with the ... health emergency by the World Health Organization and the ... care in response to Zika,s explosive spread and is calling ... therapeutics and vaccines for those who contract it. ...
(Date:2/12/2016)... N.C. , Feb. 12, 2016  Clinical Affairs leaders at ... presence in emerging areas of the world. While some companies have ... lag in their clinical activity in countries such as ... China and India ... market products in those countries. --> China ...
(Date:2/12/2016)... Va. , Feb. 12, 2016   National ... Hoey , RPh, MBA issued the following statement today ... released by the Centers for Medicare & ... raised by NCPA, beneficiary advocates and others: ... raised. We are still reviewing the full CMS analysis. ...
Breaking Medicine Technology:
Cached News: